On October 19, the U.S. Food and Drug Administration (FDA) amended the Novavax COVID-19 Vaccine, Adjuvanted emergency use authorization to authorize the use of a first booster dose for patients 18 years and older:
CY 2023 Medicare Hospital Outpatient Prospective Payment System and Ambulatory Surgical Center Payment System Final Rule
The Centers for Medicare & Medicaid Services (CMS) issued the calendar year (CY) 2023 hospital outpatient prospective payment system (OPPS) and ambulatory surgical center (ASC) payment system final rule (CMS 1772-FC).
CY 2023 Medicare Physician Fee Schedule Final Rule
The Centers for Medicare & Medicaid Services (CMS) issued a final rule that includes updates and policy changes for Medicare payments under the calendar year (CY) 2023 Physician Fee Schedule (PFS), and other Medicare Part B issues, effective on or after January 1, 2023.
CY 2023 End-Stage Renal Disease Prospective Payment System Final Rule
The Centers for Medicare & Medicaid Services (CMS) issued the calendar year (CY) 2023 End-Stage Renal Disease (ESRD) Prospective Payment System (PPS) Final Rule (CMS-1768-F) for renal dialysis services furnished to Medicare beneficiaries on or after January 1, 2023.
CY 2023 Home Health Prospective Payment System Rate Update Final Rule
The Centers for Medicare & Medicaid Services (CMS) issued the calendar year (CY) 2023 Home Health Prospective Payment System (HH PPS) Rate Update final rule (CMS-1766-F), which updates Medicare payment policies and rates for home health agencies (HHAs). This rule includes routine updates to the Medicare Home Health PPS and the home infusion therapy services’ payment rates for CY 2023, in accordance with existing statutory and regulatory requirements.
